High levels of mutated p53 indicate metastatic phenotype
High levels of mutated p53 indicate metastatic phenotype
History and ongoing work of AORTIC
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya
Subset of breast cancer patients found to benefit from neratinib in latest trial
Role of AORTIC in dealing with rising cancer rates in Africa
Impact of the liver environment upon the efficacy of induction therapy
I-SPY 2 trial shows promising development for some breast cancer patients using neratinib
New tools can help tackle flawed decision-making process for HER2- patients
Troubling differences in the success rates of breast cancer treatment across different countries
Obesity and diabetes should be taken into account when planning breast cancer treatment
Consensus on the treatment of breast cancer and early intervention using endocrine therapy
Breast cancer screening in the UK: does it work?